Virksomhedsform
Aktieselskab
Etableret
1992
Størrelse
Mellemstore
Ansatte
57
Omsætning
453 MDKK
Bruttofortj.
-7.135.000 DKK
Primært resultat (EBIT)
-93.460.000 DKK
Årets resultat
-87.791.000 DKK
Egenkapital
59 MDKK
annonce

Flere nøgletal og analyser?

Med en Bisbase Premium konto får du flere nøgletal for både virksomheder, koncerner og brancher samt adgang til eksklusive brancher indeholdende virksomheder nøje sammensat af eksperter. Og vil du lave dine egne analyser kan du også det! Det tager få minutter at få adgang - og det behøver ikke at koste dig noget!

Rang Årets resultat

Rang i branche
44/45
"Bund 10%"
Rang i Danmark
343.414/344.121
"Bund 10%"

Direktion top 3

Bestyrelse top 3

Søren Dan Johansen 27Bestyrelsesformand
Donald William Christopher Mallon 1Næstformand
Sarah Vawda 1Bestyrelsesmedlem

Legale ejere top 3

Tegningsregler

Selskabet tegnes af bestyrelsesformanden og en næstformand i forening eller af den samlede bestyrelse.

Stamoplysninger baseret på CVR

NavnHamlet Protein A/S
CVR16049441
AdresseSaturnvej 51, 8700 Horsens
BrancheFremstilling af færdige foderblandinger til landbrugsdyr [109100]
Etableret16-03-1992 (32 år)
Første regnskabsperiode01-01-1992 til 31-12-1992
VirksomhedsformAktieselskab
Antal ansatte55 (årsværk:55)
ReklamebeskyttelseNej
RevisorDeloitte Statsautoriseret Revisionspartnerselskab siden 11-05-2017
Regnskabsperiode01-01 til 31-12
Selskabskapital4.710.000 DKK
1.210.000 DKK (01-09-2006 - 21-12-2008)
2.420.000 DKK (18-05-1994 - 31-08-2006)
2.200.000 DKK (04-11-1992 - 17-05-1994)
2.000.000 DKK (13-05-1992 - 03-11-1992)
1.000.000 DKK (01-04-1992 - 12-05-1992)
Vedtægter seneste08-01-2024

Medlem af brancherne

Formål

Selskabets formål er handel og industriel produktion.

Regnskab

 202220212020
Valuta/enhed000' DKK000' DKK000' DKK
Omsætning
452.988
-6%
481.036
-2%
491.884
+35%
Bruttofortjeneste
-7.135
-
52.477
-44%
92.928
+22%
Årets resultat
-87.791
-
-13.126
-
1.351
-
Egenkapital
59.375
-59%
144.698
-5%
152.464
-3%
Balance
523.968
+1%
520.748
-7%
559.125
+10%

Ledelsesberetning

Development in activities and financesNon-financial matters

Quality
Both HAMLET PROTEIN plants in Denmark and USA meet the criteria of the feed safety standard GMP+ and the food safety
management standard ISO 22000. Our strict Feed Safety Policy ensures full traceability of both GMO and non-GMO products, allowing any batch of product to be easily traced if need be. Every week, the Company’s laboratory teams analyze 200 protein samples, taken around-the-clock from our production lines. These analyses are an important part of our customer service and a guarantee of high product quality. The sector specific knowledge and competences of the employees form an important foundation for HAMLET PROTEIN’s leading position in young animal nutrition and are a driver for future business development.

Shareholders
HAMLET PROTEIN is owned by New Nutrition Holding S.àr.l., Luxembourg, which ultimately is owned by Goldman Sachs Group Inc. (“GS Group”) and Altor Fund IV Holding AB. The Company's share capital is not divided into share classes, and the Company's articles of association do not stipulate any limits for ownership or voting rights. The Board of Directors regularly assesses whether the Company's capital structure is sound and capable of supporting the Company's growth strategy.

The Board of Directors' duties
The Board of Directors of the Company ensures that the Executive Board complies with the decisions, strategies,
and business procedures adopted by the Board of Directors. The Board of Directors meets according to a fixed schedule. In 2022, the Board of Directors held five meetings. For 2023 four meetings have been scheduled.

The Board of Directors does not rely on any subcommittees due to the limited size and complexity of the Group. Accordingly, the entire Board of Directors has focused on significant accounting policies and significant accounting estimates, and transactions with related parties, if any, as well as uncertainties and risks in its financial reporting process. Together with the auditors, the quality of the Company's internal control systems is being assessed on a regular basis, just as the auditors' independence is verified. Areas identified as particularly critical, such as foreign currency policy, procurement policy and insurance matters, are regularly discussed within the
Board of Directors.

Group relations

Recommendations for active ownership and corporate governance for private equity funds

Being owned by private equity funds, New Nutrition Holding ApS is subject to the guidelines for active ownership and corporate governance for private equity funds and their controlled enterprises as issued by the Danish Venture Capital and Private Equity Association ("DVCA"). In general, New Nutrition Holding ApS complies with these recommendations apart from the incidents where the Company's management assesses that the disclosure of specific information will be detrimental to the Group's and the Company's competitive situation.
28-04-2023

Kort